19-037977 guinea PIG complement (LYOPHILIZED) with diluent - 5ML
Ended Purchase Order Awarded Last action
- Contract number
- 75N91019P00334
- Awardee
-
Rockland Immunochemicals Inc. UEI NFKNUGEMMY18
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $10,005
Award facts
- Contract value 100% obligated
- $10,005.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Royersford, PA 19468, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $105 | |
| Original award | $9,900 |
About this award
The National Cancer Institute issued a purchase order to Rockland Immunochemicals Inc. valued at $10,005.00 for guinea pig complement (lyophilized) with diluent on May 6, 2019. Performance occurs in Royersford, Pennsylvania. The order is priced firm fixed price with an ultimate completion date of June 5, 2019. No set-aside was applied.
Quick answers
Who was awarded contract 75N91019P00334?
75N91019P00334 was awarded to Rockland Immunochemicals Inc. by National Cancer Institute (National Institutes of Health) on May 6, 2019.
How much is contract 75N91019P00334 worth?
The government has obligated $10,005 on 75N91019P00334.
Was contract 75N91019P00334 competed?
The extent of competition for 75N91019P00334 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award